1296200-27-5

Basic information

• Product Name: N-cyclopropyl-N-(3-methoxybenzyl)-6-(1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine-2-carboxamide
• CAS NO: 1296200-27-5
• Molecular Weight: 387.441
• Mol File: 1296200-27-5.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: N-cyclopropyl-N-(3-methoxybenzyl)-6-(1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine-2-carboxamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-cyclopropyl-N-(3-methoxybenzyl)-6-(1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine-2-carboxamide(1296200-27-5)
• EPA Substance Registry System: N-cyclopropyl-N-(3-methoxybenzyl)-6-(1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine-2-carboxamide(1296200-27-5)

Safety Data

• Hazardous Substances Data: 1296200-27-5(Hazardous Substances Data)

Upstream product

• 800402-07-7 6-chloro-1H-pyrrolo[2,3-b]pyridine-2-carboxylic acid 
• 269410-08-4 pyrazole-4-boronic acid pinacol ester 
• 1296202-69-1 C₁₉H₁₈ClN₃O₂ 

Relevant articles and documents

BICYCLIC HETEROARYLS AS KINASE INHIBITORS

The invention is directed to heteroaryl compounds useful as inhibitors of various kinase enzymes. In various embodiments, the invention provides a heteroaryl compound having inhibitory bioactivity with respect to a Rho kinase, an AKT kinase, a p70S6K kinase, a LIM kinase, an IKK kinase, a Flt kinase, an Aurora kinase, or a Src kinase, or any combination thereof. Compounds of the invention include bicyclic heteroaryl compounds of formula (I), which can contain a bridging nitrogen atom at a ring junction. The invention further provides methods of synthesis of compounds of the invention, pharmaceutical compositions, pharmaceutical combinations, and methods of treatment of malconditions using compounds of the invention.